annual CFI:
-$184.66M-$287.54M(-279.48%)Summary
- As of today (September 17, 2025), EWTX annual cash flow from investing activities is -$184.66 million, with the most recent change of -$287.54 million (-279.48%) on December 31, 2024.
- During the last 3 years, EWTX annual CFI has risen by +$57.57 million (+23.77%).
- EWTX annual CFI is now -279.48% below its all-time high of $102.89 million, reached on December 31, 2023.
Performance
EWTX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$162.17M-$206.06M(-469.42%)Summary
- As of today (September 17, 2025), EWTX quarterly cash flow from investing activities is -$162.17 million, with the most recent change of -$206.06 million (-469.42%) on June 30, 2025.
- Over the past year, EWTX quarterly CFI has dropped by -$199.53 million (-533.97%).
- EWTX quarterly CFI is now -430.67% below its all-time high of $49.04 million, reached on March 31, 2023.
Performance
EWTX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$71.98M-$199.53M(-156.44%)Summary
- As of today (September 17, 2025), EWTX TTM cash flow from investing activities is -$71.98 million, with the most recent change of -$199.53 million (-156.44%) on June 30, 2025.
- Over the past year, EWTX TTM CFI has increased by +$108.55 million (+60.13%).
- EWTX TTM CFI is now -156.44% below its all-time high of $127.55 million, reached on March 31, 2025.
Performance
EWTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
EWTX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -279.5% | -534.0% | +60.1% |
| 3 y3 years | +23.8% | -10000.0% | -619.6% |
| 5 y5 years | -10000.0% | -10000.0% | -10000.0% |
EWTX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -279.5% | +23.8% | -430.7% | +39.6% | -156.4% | +66.4% |
| 5 y | 5-year | -279.5% | +23.8% | -430.7% | +39.6% | -156.4% | +74.3% |
| alltime | all time | -279.5% | +23.8% | -430.7% | +39.6% | -156.4% | +74.3% |
EWTX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$162.17M(-469.4%) | -$71.98M(-156.4%) |
| Mar 2025 | - | $43.90M(+109.8%) | $127.55M(-169.1%) |
| Dec 2024 | -$184.66M(-279.5%) | $20.92M(-17.5%) | -$184.66M(+3.4%) |
| Sep 2024 | - | $25.36M(-32.1%) | -$178.59M(-1.1%) |
| Jun 2024 | - | $37.37M(-113.9%) | -$180.54M(-15.8%) |
| Mar 2024 | - | -$268.31M(-1094.4%) | -$214.46M(-308.4%) |
| Dec 2023 | $102.89M(-245.8%) | $26.98M(+15.2%) | $102.89M(>+9900.0%) |
| Sep 2023 | - | $23.42M(+580.4%) | $307.00K(-100.6%) |
| Jun 2023 | - | $3.44M(-93.0%) | -$49.43M(-6.6%) |
| Mar 2023 | - | $49.04M(-164.9%) | -$52.92M(-25.0%) |
| Dec 2022 | -$70.58M | -$75.60M(+187.2%) | -$70.58M(-468.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$26.32M(>+9900.0%) | $19.14M(+38.2%) |
| Jun 2022 | - | -$46.00K(-100.1%) | $13.85M(-109.5%) |
| Mar 2022 | - | $31.39M(+122.3%) | -$146.07M(-39.7%) |
| Dec 2021 | -$242.23M(+893.5%) | $14.12M(-144.7%) | -$242.23M(-13.7%) |
| Sep 2021 | - | -$31.61M(-80.2%) | -$280.53M(+12.7%) |
| Jun 2021 | - | -$159.97M(+147.0%) | -$248.92M(+179.2%) |
| Mar 2021 | - | -$64.77M(+167.9%) | -$89.14M(+265.7%) |
| Dec 2020 | -$24.38M(>+9900.0%) | -$24.18M(>+9900.0%) | -$24.38M(>+9900.0%) |
| Jun 2020 | - | -$188.00K(+1988.9%) | -$197.00K(+2088.9%) |
| Mar 2020 | - | -$9000.00 | -$9000.00 |
| Dec 2019 | -$180.00K | - | - |
FAQ
- What is Edgewise Therapeutics, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. annual CFI year-on-year change?
- What is Edgewise Therapeutics, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. quarterly CFI year-on-year change?
- What is Edgewise Therapeutics, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. TTM CFI year-on-year change?
What is Edgewise Therapeutics, Inc. annual cash flow from investing activities?
The current annual CFI of EWTX is -$184.66M
What is the all time high annual CFI for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high annual cash flow from investing activities is $102.89M
What is Edgewise Therapeutics, Inc. annual CFI year-on-year change?
Over the past year, EWTX annual cash flow from investing activities has changed by -$287.54M (-279.48%)
What is Edgewise Therapeutics, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of EWTX is -$162.17M
What is the all time high quarterly CFI for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high quarterly cash flow from investing activities is $49.04M
What is Edgewise Therapeutics, Inc. quarterly CFI year-on-year change?
Over the past year, EWTX quarterly cash flow from investing activities has changed by -$199.53M (-533.97%)
What is Edgewise Therapeutics, Inc. TTM cash flow from investing activities?
The current TTM CFI of EWTX is -$71.98M
What is the all time high TTM CFI for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high TTM cash flow from investing activities is $127.55M
What is Edgewise Therapeutics, Inc. TTM CFI year-on-year change?
Over the past year, EWTX TTM cash flow from investing activities has changed by +$108.55M (+60.13%)